Standard BioTools Inc. (NASDAQ:LAB – Get Free Report) was the target of a large growth in short interest in September. As of September 30th, there was short interest totalling 3,520,000 shares, a growth of 28.5% from the September 15th total of 2,740,000 shares. Approximately 4.6% of the shares of the stock are short sold. Based […]
Standard BioTools and SomaLogic Reportedly Near Merger Deal themiddlemarket.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themiddlemarket.com Daily Mail and Mail on Sunday newspapers.
Structure Therapeutics (NASDAQ:GPCR – Free Report) had its target price increased by SVB Leerink from $46.00 to $97.00 in a research report released on Friday morning, FlyOnTheWall reports. GPCR has been the topic of several other reports. Piper Sandler assumed coverage on shares of Structure Therapeutics in a research note on Thursday, July 27th. They […]
Shares of Structure Therapeutics Inc. (NASDAQ:GPCR – Get Free Report) have been assigned an average rating of “Buy” from the six ratings firms that are covering the firm, MarketBeat Ratings reports. Six investment analysts have rated the stock with a buy rating. The average 1-year target price among brokers that have updated their coverage on […]